Who owns Biomarin Pharmaceutical Inc?
- CUSIP Number: 09061G901
Tip: Access positions for across all investors
Analyze quarterly positions in Biomarin Pharmaceutical with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Biomarin Pharmaceutical stock
Who bought or sold Biomarin Pharmaceutical Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Groupama Asset Managment | 699k | $18k | 100% | Mar 2024 |
|
| Jane Street | 213k | $19M | 9% | Mar 2024 |
|
| Group One Trading | 108k | $9.4M | 112% | Mar 2024 |
|
| Simplex Trading | 39k | $3.4M | -27% | Mar 2024 |
|
Who sold out of Biomarin Pharmaceutical?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Jpmorgan Chase & Co | Dec 2023 | 50k | $4.8M |